CEO: Barry D. Quart

Sector: Healthcare

Exchange: NASDAQ Capital Market

Country: USA

Description: Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.


Key numbers

Market Capitalization:2035163900
Shares Outstanding: 90051500
Float: 89259677
Next Earning Date:2020-02-29
TTm EPS: -2.4898
TTm Dividend Rate:
200 days moving average:20.16
50 days moving average: 23.88
One day percent Change: -3.42



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,